Cutaneous Reactions to Targeted Therapies in Children with CNS Tumors: A Cross-Sectional Study
February 2019
in “
Pediatric Blood & Cancer
”
Studysummary In this study, 96% of children with CNS tumors receiving MAPK and mTOR inhibitors experienced common, treatable skin reactions, occasionally requiring therapy adjustments.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on onlinelibrary.wiley.com →